Advanced

Insulinglarin - en systematisk översikt av behandlingsstudier. Inga dokumenterade fördelar med Lantus jämfört med NPH-insulin

Björk Linné, Agneta and Liedholm, Hans LU (2004) In Läkartidningen 101(30-31). p.7-2402
Please use this url to cite or link to this publication:
author
organization
alternative title
Insulin glargine--a systematic review of clinical studies. No documented advantages with Lantus compared to NPH insulin
publishing date
type
Contribution to journal
publication status
published
subject
keywords
English Abstract, Type II: drug therapy, Diabetes Mellitus, Clinical Trials, Comparative Study, Type I: drug therapy, Evidence-Based Medicine, Human, Hypoglycemic Agents: therapeutic use, Insulin: analogs & derivatives, Insulin: therapeutic use, Insulin, Isophane: therapeutic use, Meta-Analysis
in
Läkartidningen
volume
101
issue
30-31
pages
7 - 2402
publisher
Swedish Medical Association
ISSN
0023-7205
language
Swedish
LU publication?
yes
id
8abda147-f81f-4e11-a87d-645f6c4bbf30 (old id 126641)
alternative location
http://ltarkiv.lakartidningen.se/artNo28900
date added to LUP
2007-07-13 14:30:56
date last changed
2016-04-16 04:28:14
@article{8abda147-f81f-4e11-a87d-645f6c4bbf30,
  author       = {Björk Linné, Agneta and Liedholm, Hans},
  issn         = {0023-7205},
  keyword      = {English Abstract,Type II: drug therapy,Diabetes Mellitus,Clinical Trials,Comparative Study,Type I: drug therapy,Evidence-Based Medicine,Human,Hypoglycemic Agents: therapeutic use,Insulin: analogs & derivatives,Insulin: therapeutic use,Insulin,Isophane: therapeutic use,Meta-Analysis},
  language     = {swe},
  number       = {30-31},
  pages        = {7--2402},
  publisher    = {Swedish Medical Association},
  series       = {Läkartidningen},
  title        = {Insulinglarin - en systematisk översikt av behandlingsstudier. Inga dokumenterade fördelar med Lantus jämfört med NPH-insulin},
  volume       = {101},
  year         = {2004},
}